Document Detail


Meta-Analysis of Long-Term Outcomes for Drug-Eluting Stents Versus Bare-Metal Stents in Primary Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial Infarction.
MedLine Citation:
PMID:  22221949     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The use of drug-eluting stents (DESs) in primary percutaneous coronary intervention (PPCI) has shown early benefit over bare-metal stents (BMSs) in decreasing adverse cardiac events. However, there are concerns regarding the increased risk of late and very late stent thrombosis (ST) after DES use. With the paucity of ST events individual trials may have been underpowered to detect significant differences. We sought to perform a meta-analysis to evaluate the available literature examining the outcomes of DESs and BMSs in PPCI after ≥3 years of follow-up. We analyzed 8 randomized clinical trials (RCTs) and 5 observational studies comparing DESs to BMSs in PPCI. Clinical end-point data were analyzed for RCTs and observational studies separately using random-effect models. RCTs included 5,797 patients in whom first-generation DESs (sirolimus- or paclitaxel-eluting stents) were compared to BMS control arms. Patients receiving DESs had a significantly lower risk of target lesion revascularization (odds ratio [OR] 0.48, confidence interval [CI] 0.37 to 0.61), target vessel revascularization (OR 0.53, CI 0.42 to 0.66), and accordingly major adverse cardiac events (OR 0.69; CI 0.56 to 0.84). Incidence of ST was not different between groups (OR 1.02, CI 0.76 to 1.37). There was no significant difference in mortality (OR 0.88, CI 0.68 to 1.12) or recurrent myocardial infarction (OR 0.97; CI 0.61 to 1.54). Among observational studies (n = 4,650) fewer studies reported on target lesion revascularization and target vessel revascularization, but the trend remained in favor of DESs. A small but statistically significant increase in ST was noted with DES use (OR 1.62, CI 1.18 to 2.21) at ≥3 years of follow up, without evidence of recurrent myocardial infarction. Those receiving DESs had a significantly lower mortality compared to those receiving BMSs (OR, 0.65, 95% CI 0.53 to 0.80, p <0.001). In conclusion, this meta-analysis of RCTs examining the long-term outcomes of first-generation DESs versus BMSs in PPCI, DES use resulted in decreased repeat revascularization with no increase in ST, mortality, or recurrent myocardial infarction.
Authors:
Eric L Wallace; Ahmed Abdel-Latif; Richard Charnigo; David J Moliterno; Bruce Brodie; Rahul Matnani; Khaled M Ziada
Related Documents :
22609869 - Focus on cardiac amyloidosis: a single-center experience with a long-term follow-up.
22156269 - β-blockade in the perioperative management of the patient with cardiac disease undergoi...
21635989 - Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasu...
22835669 - Assessment of myocardial scarring improves risk stratification in patients evaluated fo...
22901969 - Bleeding complications with regional adaptation of a prolonged bivalirudin regimen for ...
21574239 - Prognostic value of cardiac troponin-i or troponin-t elevation following nonemergent pe...
16945819 - Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary ...
11985919 - Time to onset of regional relaxation: feasibility, variability and utility of a novel i...
25372919 - Modes of induced cardiac arrest: hyperkalemia and hypocalcemia - literature review.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-3
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, Kentucky.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relation of Systemic-to-Pulmonary Artery Collateral Flow in Single Ventricle Physiology to Palliativ...
Next Document:  Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography.